57 results
8-K
EX-99.1
ME
23andMe Holding Co - Ordinary Shares
7 Feb 24
23andMe Reports Third Quarter Fiscal 2024 Financial Results
4:03pm
for the three and nine months ended December 31, 2023 and 2022.
(2)Certain department expenses such as Finance, Legal, Regulatory and Supplier Quality
8-K
ME
23andMe Holding Co - Ordinary Shares
13 Nov 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:06pm
. (the “Company”) received a deficiency letter (the “Nasdaq Letter”) from the Nasdaq Listing Qualifications Department, notifying the Company that the Company
8-K
EX-99.1
ME
23andMe Holding Co - Ordinary Shares
8 Nov 23
23andMe Reports Second Quarter Fiscal 2024 Financial Results
4:29pm
for the three or six months ended September 30, 2023 and 2022.
(2)Certain department expenses such as Finance, Legal, Regulatory and Supplier Quality
8-K
EX-10.1
j4j4a1
27 Oct 23
Departure of Directors or Certain Officers
4:06pm
8-K
EX-99.1
hzlye2 6gqkf9042da
8 Aug 23
23andMe Reports FY2024 First Quarter Financial Results
4:10pm
DEFR14A
kfxu3sv
26 Jul 23
Revised proxy
9:14pm
8-K
EX-99.1
fkp1v l0s5
25 May 23
23andMe Reports FY2023 Fourth Quarter and Full Year Financial Results
4:08pm
8-K
EX-10.1
et3x7mqgm75yj
9 Dec 22
Departure of Directors or Certain Officers
8:05am
424B3
ljvxwdavt749plik7dr8
7 Nov 22
Prospectus supplement
4:33pm
8-K
EX-99.1
o126fg1p
7 Nov 22
23andMe Reports FY2023 Second Quarter Financial Results
4:06pm
POS AM
nbxrzw6r7gqb0 92914
3 Nov 22
Prospectus update (post-effective amendment)
4:14pm
424B3
9de8fq9yy14g5
16 Aug 22
Prospectus supplement
6:12pm